Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović +11 more
wiley +1 more source
Lunar synchronization of hemostasis and immunity validates prophetic timing of hijama therapy: A multicenter study from Yemen. [PDF]
Ali NT +15 more
europepmc +1 more source
Droplet microfluidics: Enabling the tailored fabrication of hydrogel particles
Droplet microfluidics enables precise, versatile fabrication of hydrogel particles with controlled size, composition, and structure. This review summarizes fundamental principles, engineering strategies, and emerging applications, providing a framework for advancing microfluidic hydrogel technologies.
Zhongqiao Gan, Xu Hou
wiley +1 more source
Pathogenic interplay between markedly elevated plasma lipoprotein(a) levels and prothrombotic mechanisms: a case report. [PDF]
Biolo M +8 more
europepmc +1 more source
Clinicians often concurrently tackle critical challenges including emergency hemorrhage, secondary infection, and the elusive tracking of biodegradation of conventional hemostatic agents for complex wounds. Here, we report an intelligent hemostatic sponge (spCS@AIE) by incorporating aggregation‐induced emission (AIE) nanoparticles with short‐wave ...
Zhicheng Liu +12 more
wiley +1 more source
Phase-specific dynamics of coagulation factors V, VIII, and XIII during liver transplantation: insights from a prospective study. [PDF]
Thaler S +6 more
europepmc +1 more source
Acquired platelet dysfunction induced by infection in an older patient: Severe hemorrhage despite normal platelet count. [PDF]
Jiang Y +6 more
europepmc +1 more source
Biphasic modulation of large-fiber excitability accompanied by dynamic nerve-intrinsic immune activation following CFA-induced peripheral inflammation in mice. [PDF]
Berkowitz S +10 more
europepmc +1 more source

